Ocugen to Present at Three Upcoming Conferences

Ocugen to Present at Three Upcoming Conferences

MALVERN, PA — Ocugen, Inc., (NASDAQ: OCGN) a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases, announced that Shankar Musunuri, Ph.D., Chairman, CEO and Co-Founder of Ocugen, will give presentations at three upcoming conferences.

Dr. Musunuri will present at the Cantor Global Healthcare Conference, held October 4, 2019, in New York City, the Chardan Genetic Medicines Conference, held October 7, 2019, in New York City and at the Ophthalmology Innovation Summit (OIS), held October 10, 2019, in San Francisco.

Cantor Global Healthcare Conference:
Date: Friday, October 4, 2019
Time: 8:55am ET
Location: Grand Ballroom 2; Intercontinental New York Barclay Hotel

An audio webcast will be accessible for 90 days following the presentation via the following link: https://www.ir.ocugen.com

READ:  TELA Bio Announces Interim Analysis from BRAVO Study of OviTex® for Ventral Hernia Repair

Chardan Genetic Medicines Conference:
Date: Monday, October 7, 2019
Time: 4:15pm ET
Location: Ambassador Room; Westin New York Grand Central

An audio webcast will be accessible for 90 days following the presentation via the following link: https://www.ir.ocugen.com

Ophthalmology Innovation Summit:
Date: Thursday, October 10, 2019
Time: 11:37am PT
Location: Hilton San Francisco Union Square

Source: Ocugen, Inc., 5 Great Valley Parkway, Suite 160, Malvern PA 19355

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.

Buy Us a Cup of Coffee